Xianjie Jiang

4.8k total citations · 6 hit papers
42 papers, 2.9k citations indexed

About

Xianjie Jiang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xianjie Jiang has authored 42 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Xianjie Jiang's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (10 papers) and Circular RNAs in diseases (8 papers). Xianjie Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (10 papers) and Circular RNAs in diseases (8 papers). Xianjie Jiang collaborates with scholars based in China, Saudi Arabia and United States. Xianjie Jiang's co-authors include Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Bo Xiang, Jie Wang, Xiangying Deng, Can Guo, Yong Li, Qianjin Liao and Xiaoling Li and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Xianjie Jiang

40 papers receiving 2.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

2019 1.1k citations Xianjie Jiang, Jie Wang et al. Molecular Cancer profile →
The role of microenvironment in tumor angiogenesis

2020 514 citations Xianjie Jiang, Jie Wang et al. Journal of Experimental & Clinical Cancer Research profile →
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments

2021 304 citations Xianjie Jiang, Yongzhen Mo et al. Molecular Cancer profile →
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

2023 121 citations Xuemeng Xu, Peng Qiu et al. Experimental & Molecular Medicine profile →
Endoplasmic reticulum stress—a key guardian in cancer

2024 62 citations Wenlong Zhang, Yidan Shi et al. Cell Death Discovery profile →
The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications

2025 36 citations Xianjie Jiang, Peng Qiu et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xianjie Jiang China	19	1.5k	997	949	782	413	42	2.9k
Jamal Majidpoor Iran	30	1.5k 1.0×	1.1k 1.1×	974 1.0×	866 1.1×	312 0.8×	67	3.1k
Yan Zheng China	27	1.8k 1.2×	682 0.7×	1.3k 1.4×	552 0.7×	359 0.9×	48	3.0k
Aija Linē Latvia	26	1.9k 1.3×	768 0.8×	1.0k 1.1×	635 0.8×	321 0.8×	63	2.9k
David Kung‐Chun Chiu Hong Kong	21	2.2k 1.5×	743 0.7×	1.4k 1.5×	655 0.8×	367 0.9×	36	3.3k
Jessalyn M. Ubellacker United States	17	1.5k 1.0×	1.2k 1.2×	859 0.9×	704 0.9×	944 2.3×	29	3.1k
Jinyang Li United States	25	1.3k 0.9×	985 1.0×	610 0.6×	470 0.6×	258 0.6×	51	2.4k
Jiang Liu China	17	1.9k 1.3×	1.4k 1.4×	1.1k 1.2×	901 1.2×	950 2.3×	33	3.4k
Chao Chen China	29	1.4k 0.9×	817 0.8×	996 1.0×	427 0.5×	320 0.8×	130	2.7k
Peter W. Szlosarek United Kingdom	27	1.3k 0.9×	673 0.7×	1.1k 1.2×	506 0.6×	529 1.3×	65	3.1k
Nayiyuan Wu China	24	1.7k 1.2×	742 0.7×	1.1k 1.1×	426 0.5×	557 1.3×	84	2.9k

Countries citing papers authored by Xianjie Jiang

Since Specialization

Citations

This map shows the geographic impact of Xianjie Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianjie Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianjie Jiang more than expected).

Fields of papers citing papers by Xianjie Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianjie Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianjie Jiang. The network helps show where Xianjie Jiang may publish in the future.

Co-authorship network of co-authors of Xianjie Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xianjie Jiang. A scholar is included among the top collaborators of Xianjie Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianjie Jiang. Xianjie Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Haoneng, Peng Qiu, Linda Oyang, et al.. (2025). Fusion genes in cancers: Biogenesis, functions, and therapeutic implications. Genes & Diseases. 12(5). 101536–101536.

Qiu, Peng, Lujuan Wang, Ying Long, et al.. (2025). SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression. Journal of Advanced Research. 79. 505–520. 3 indexed citations

Xu, Xuemeng, Peng Qiu, Yaqian Han, et al.. (2025). CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance. Molecular Cancer. 24(1). 36–36. 8 indexed citations

Tan, Shiming, Shizhen Li, Longzheng Xia, et al.. (2025). Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway. International Journal of Oncology. 66(3). 1 indexed citations

Han, Yaqian, Shizhen Li, Linda Oyang, et al.. (2025). Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential. Cellular Oncology. 48(5). 1219–1244. 1 indexed citations

Qiu, Peng, Xuemeng Xu, Wenlong Zhang, et al.. (2025). Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance. International Journal of Biological Sciences. 21(7). 2991–3010. 3 indexed citations

Wang, Jie, Meifeng Wang, X. Zeng, et al.. (2025). Targeting membrane contact sites to mediate lipid dynamics: innovative cancer therapies. Cell Communication and Signaling. 23(1). 89–89.

Jiang, Xianjie, Peng Qiu, Linda Oyang, et al.. (2025). The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. Journal of Hematology & Oncology. 18(1). 40–40. 36 indexed citations breakdown →

Wang, Rong, et al.. (2024). Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways. Experimental Hematology and Oncology. 13(1). 46–46. 15 indexed citations

10.

Jiang, Xianjie, Qiu Peng, Mingjing Peng, et al.. (2024). Cellular metabolism: A key player in cancer ferroptosis. Cancer Communications. 44(2). 185–204. 36 indexed citations

11.

Jiang, Xianjie, Mingjing Peng, Qiang Liu, et al.. (2024). Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation. Molecular Cancer. 23(1). 151–151. 13 indexed citations

12.

Zhang, Wenlong, Yidan Shi, Linda Oyang, et al.. (2024). Endoplasmic reticulum stress—a key guardian in cancer. Cell Death Discovery. 10(1). 343–343. 62 indexed citations breakdown →

13.

Xia, Longzheng, Jinguan Lin, Mingjing Peng, et al.. (2024). Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination. International Journal of Biological Sciences. 20(4). 1125–1141. 8 indexed citations

14.

Xu, Xuemeng, Peng Qiu, Xianjie Jiang, et al.. (2023). Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Experimental & Molecular Medicine. 55(7). 1357–1370. 121 indexed citations breakdown →

15.

Qiu, Peng, Lujuan Wang, Liang Zuo, et al.. (2023). HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor. Cancer Gene Therapy. 31(1). 9–17. 31 indexed citations

16.

Ge, Junshang, Jie Wang, Fang Xiong, et al.. (2021). Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1. Cancer Research. 81(19). 5074–5088. 113 indexed citations

17.

Zhu, Kunjie, Junshang Ge, Yi He, et al.. (2021). Bioinformatics Analysis of the Signaling Pathways and Genes of Gossypol Induce Death of Nasopharyngeal Carcinoma Cells. DNA and Cell Biology. 40(8). 1052–1063. 3 indexed citations

18.

Mo, Yongzhen, Yumin Wang, Shuai Zhang, et al.. (2021). Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Molecular Cancer. 20(1). 112–112. 94 indexed citations

19.

Jiang, Xianjie, Jie Wang, Xiangying Deng, et al.. (2020). The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research. 39(1). 204–204. 514 indexed citations breakdown →

20.

Zhu, Kunjie, Zhaojian Gong, Xianjie Jiang, et al.. (2020). A review of linc00673 as a novel lncRNA for tumor regulation. International Journal of Medical Sciences. 18(2). 398–405. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact